Multiple sclerosis: open trials in Greece

13 open trials have a site in Greece. Registry data; only the trial team decides who can take part.

NCT07067463
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC
Henry Dunant Hospital Center, Athens · 401 General Military Hospital of Athens, Athens · Eginitio Hospital, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · Metropolitan General Hospital Healthcare Facilities Operation And Management Single Member S.A., Cholargos · General University Hospital of Larissa, Larissa · St. Luke's Hospital S.A., Thessaloniki
Registry updated 2026-11-03
2023-504358-36-00
Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis
Trial Treatment · Phase 3 · Sanofi-Aventis Recherche & Developpement
University General Hospital of Ioannina, Ioannina · University General Hospital of Thessaloniki - AHEPA, Thessaloniki
Registry updated 2026-10-28
NCT07299019
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC
401 General Military Hospital of Athens, Athens · Eginitio Hospital, Athens · Henry Dunant Hospital Center, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · Metropolitan General Hospital Healthcare Facilities Operation And Management Single Member S.A., Cholargos · General University Hospital of Larissa, Larissa
Registry updated 2026-10-27
NCT06846281
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
University General Hospital Attikon, Athens · General University Hospital of Larissa, Larissa · St. Luke's Hospital S.A., Thessaloniki
Registry updated 2026-10-26
NCT05003388
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for MS
Trial Treatment · Phase 1 · The Foundation for Orthopaedics and Regenerative Medicine
Prodromos Stem Cell Institute, Athens
Registry updated 2026-10-20
NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Novartis Investigative Site, Athens · Novartis Investigative Site, Chaïdári · Novartis Investigative Site, Ioannina · Novartis Investigative Site, Larissa · Novartis Investigative Site, Thessaloniki
Registry updated 2026-10-13
NCT07325292
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Trial Treatment · Phase 3 · Sanofi
401 General Military Hospital of Athens, Athens · University General Hospital of Ioannina, Ioannina · General University Hospital of Larissa, Larissa · University General Hospital of Thessaloniki - AHEPA, Thessaloniki
Registry updated 2026-10-13
2024-512707-40-00
A Phase 2 Study of Obexelimab in Patients with Relapsing Multiple Sclerosis
Trial Treatment · Phase 2 · Zenas Biopharma (USA) LLC
University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · General University Hospital of Larissa, Larissa
Registry updated 2026-08-27
2025-521546-23-00
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
Trial Treatment · Phase 3 · Novartis Pharma AG
Eginitio Hospital, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · Metropolitan General Hospital Healthcare Facilities Operation And Management Single Member S.A., Cholargos · University General Hospital of Ioannina, Ioannina · General University Hospital of Larissa, Larissa · St. Luke's Hospital S.A., Thessaloniki · University General Hospital of Thessaloniki - AHEPA, Thessaloniki
Registry updated 2026-07-30
2025-521910-24-00
Effects of CLADribine tablets on the Immune Synapse, in Relapsing Multiple Sclerosis (RMS) patients_CLADIS.
Trial Treatment · Phase 4 · Aristotle University Of Thessaloniki
Papageorgiou Hospital, Thessaloniki · University General Hospital of Thessaloniki - AHEPA, Thessaloniki
Registry updated 2026-07-03
NCT07630311
"Balance, Gait, and Motion Analysis in Multiple Sclerosis"
Research · University of Patras
Division of Physical Medicine and Rehabilitation/Department of Surgery, University of Ioannina Medical School, Ioannina · Department of Physiotherapy of the School of Health Rehabilitation Sciences, University of Patras, Pátrai
Registry updated 2026-06-24
NCT06486779
Kesimpta (Ofatumumab) in Greek Multiple Sclerosis Patients - an Observational Study
Research · Novartis Pharmaceuticals
Novartis Investigative Site, Alexandroupoli · Novartis Investigative Site, Athens · Novartis Investigative Site, Chaïdári · Novartis Investigative Site, Crete Heraklion · Novartis Investigative Site, Ioannina · Novartis Investigative Site, Larissa · Novartis Investigative Site, Pátrai · Novartis Investigative Site, Thessaloniki
Registry updated 2026-06-11
NCT04237675
Postoperative Relapses in MS Patients
Research · University of Athens
Aretaieio Hospital, University of Athens, Athens · Aretaieio Hospital, Athens
Registry updated 2020-01-23

All Multiple sclerosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error